Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1990 Nov;49(11):956–957. doi: 10.1136/ard.49.11.956-b

Correlation of iron exchange between the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one(L1) and transferrin and possible antianaemic effects of L1 in rheumatoid arthritis.

G Vreugdenhil, A J Swaak, C de Jeu-Jaspers, H G van Eijk
PMCID: PMC1004279  PMID: 2256752

Full text

PDF
956

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beamish M. R., Davies A. G., Eakins J. D., Jacobs A., Trevett D. The measurement of reticuloendothelial iron release using iron-dextran. Br J Haematol. 1971 Dec;21(6):617–622. doi: 10.1111/j.1365-2141.1971.tb02724.x. [DOI] [PubMed] [Google Scholar]
  2. Biemond P., van Eijk H. G., Swaak A. J., Koster J. F. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases. J Clin Invest. 1984 Jun;73(6):1576–1579. doi: 10.1172/JCI111364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blake D. R., Hall N. D., Bacon P. A., Dieppe P. A., Halliwell B., Gutteridge J. M. Effect of a specific iron chelating agent on animal models of inflammation. Ann Rheum Dis. 1983 Feb;42(1):89–93. doi: 10.1136/ard.42.1.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cartwright G. E., Lee G. R. The anaemia of chronic disorders. Br J Haematol. 1971 Aug;21(2):147–152. doi: 10.1111/j.1365-2141.1971.tb03424.x. [DOI] [PubMed] [Google Scholar]
  5. Giordano N., Sancasciani S., Borghi C., Fioravanti A., Marcolongo R. Antianemic and potential anti-inflammatory activity of desferrioxamine: possible usefulness in rheumatoid arthritis. Clin Exp Rheumatol. 1986 Jan-Mar;4(1):25–29. [PubMed] [Google Scholar]
  6. Hewitt S. D., Hider R. C., Sarpong P., Morris C. J., Blake D. R. Investigation of the anti-inflammatory properties of hydroxypyridinones. Ann Rheum Dis. 1989 May;48(5):382–388. doi: 10.1136/ard.48.5.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kontoghiorghes G. J., Aldouri M. A., Hoffbrand A. V., Barr J., Wonke B., Kourouclaris T., Sheppard L. Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Br Med J (Clin Res Ed) 1987 Dec 12;295(6612):1509–1512. doi: 10.1136/bmj.295.6612.1509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. O'Connell M., Halliwell B., Moorhouse C. P., Aruoma O. I., Baum H., Peters T. J. Formation of hydroxyl radicals in the presence of ferritin and haemosiderin. Is haemosiderin formation a biological protective mechanism? Biochem J. 1986 Mar 15;234(3):727–731. doi: 10.1042/bj2340727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Polson R. J., Jawad A. S., Bomford A., Berry H., Williams R. Treatment of rheumatoid arthritis with desferrioxamine. Q J Med. 1986 Dec;61(236):1153–1158. [PubMed] [Google Scholar]
  10. Vreugdenhil G., Swaak A. J., Kontoghiorghes G. J., van Eijk H. G. Efficacy and safety of oral iron chelator L1 in anaemic rheumatoid arthritis patients. Lancet. 1989 Dec 9;2(8676):1398–1399. doi: 10.1016/s0140-6736(89)92011-4. [DOI] [PubMed] [Google Scholar]
  11. Vreugdenhil G., Wognum A. W., van Eijk H. G., Swaak A. J. Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness. Ann Rheum Dis. 1990 Feb;49(2):93–98. doi: 10.1136/ard.49.2.93. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES